MBX Biosciences, Inc Common Stock

Yahoo Finance • 20 days ago

MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award

MBX Biosciences, Inc. CARMEL, Ind. and BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of nove... Full story

Yahoo Finance • 22 days ago

3 Overlooked Stocks Set to Soar in 2026

Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize growth for investors. Axsome Therapeutics(NASDAQ: AXSM) is a mid-cap with only three approved therapies, while sma... Full story

Yahoo Finance • last month

Aaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share Purchase

What happened According to a filing with the Securities and Exchange Commission dated April 21, 2026, Aaron Wealth Advisors LLC bought 1,098,176 shares of MBX Biosciences(NASDAQ:MBX) during the first quarter. The estimated value of the tr... Full story

Yahoo Finance • 2 months ago

Wednesday 3/18 Insider Buying Report: MDRR, MBX

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Friday, Medalist Diversified's CHAIRMAN,... Full story

Yahoo Finance • 5 months ago

Microbix Schedules Release of Results for Q4 Fiscal 2025

MISSISSAUGA, Ontario, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, mana... Full story

Yahoo Finance • 6 months ago

Microbix Launches New Products to Support H3N2 Flu Testing

MISSISSAUGA, Ontario, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QAPs™ quality assessment prod... Full story

Yahoo Finance • 6 months ago

Microbix Announces Initiation of Normal Course Issuer Bid

MISSISSAUGA, Ontario, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Norm... Full story

Yahoo Finance • 6 months ago

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones

Key Points Boston-based MPM BioImpact sold 1.3 million shares of MBX Biosciences worth an estimated $14.8 million in the third quarter. The move marked a full exit for MPM BioImpact, which reported holding no shares of MBX at the end of t... Full story

Yahoo Finance • 6 months ago

Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

MISSISSAUGA, Ontario and MEXICO CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and Seegene Mexico S.A.P.I. de C.V. (Seegene Mex... Full story

Yahoo Finance • 8 months ago

Microbix Presenting at Muskoka Capital Event

MISSISSAUGA, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskok... Full story

Yahoo Finance • 8 months ago

MBX Biosciences stock down on pricing upsized public offering at $18.00 per share

MBX Biosciences (NASDAQ:MBX [https://seekingalpha.com/symbol/MBX]) has priced [https://seekingalpha.com/pr/20243761-mbx-biosciences-announces-pricing-of-upsized-public-offering] its public offering of 11,108,055 shares at $18.00 per share.... Full story

Yahoo Finance • 8 months ago

MBX Biosciences Announces Pricing of Upsized Public Offering

CARMEL, Ind., Sept. 24, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine... Full story

Yahoo Finance • 8 months ago

Microbix Assisting EMQN with Second Genetic-Test EQA Program

MISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and EMQN CIC (EMQN), a global su... Full story

Yahoo Finance • 8 months ago

Stock Indexes Post New Record Highs on AI Optimism

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Monday closed up +0.44%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/f... Full story

Yahoo Finance • 8 months ago

MBX Biosciences files for public offering of 10M shares

* MBX Biosciences (NASDAQ:MBX [https://seekingalpha.com/symbol/MBX]) has fileded a proposed public offering of 10M shares of common stock. * The company also plans to grant underwriters a 30-day option to purchase up to 1.5M additional... Full story

Yahoo Finance • 8 months ago

MBX Biosciences Announces Proposed Public Offering

CARMEL, Ind., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine... Full story

Yahoo Finance • 8 months ago

Stocks Supported as Chip Makers and AI-Infrastructure Companies Rally

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.18%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story

Yahoo Finance • 8 months ago

Invesco 500 Momentum ETF declares quarterly distribution of $0.1917

* Invesco 500 Momentum ETF (NYSEARCA:SPMO [https://seekingalpha.com/symbol/SPMO]) - $0.1917 [https://www.invesco.com/us/financial-products/etfs/product-detail?audienceType=Advisor&productId=ETF-SPMO]. * 30-Day SEC Yield of 0.75% as of... Full story

Yahoo Finance • 8 months ago

Stock Indexes Consolidate Below Last Week's Record Highs

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.18%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story

Yahoo Finance • 8 months ago

MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension

Statistically significant responder rate achieved at 12 weeks with zero contribution from rescue therapy (PRN) and further improvement sustained in open-label extension (OLE) Positive findings in bone and kidney biomarkers All patients c... Full story